Evidence map›Paper›PMID 38693151›Full record

ArticleNature communications2024

Author Correction: Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer.

Mary L Stackpole, Weihua Zeng, Shuo Li, Chun-Chi Liu, Yonggang Zhou, Shanshan He, Angela Yeh, Ziye Wang, Fengzhu Sun, Qingjiao Li and 30 more

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors.

Mary L Stackpole *Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0003-4432-6718
Weihua Zeng *Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Shuo Li *Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0002-1960-6016
Chun-Chi LiuEarlyDiagnostics, Inc., 570 Westwood Plaza, Los Angeles, CA, 90095, USA.
Yonggang ZhouDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Shanshan HeDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Angela YehDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Ziye WangDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Fengzhu SunDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, 90089, USA.ORCID http://orcid.org/0000-0002-8552-043X
Qingjiao LiThe Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.ORCID http://orcid.org/0000-0002-7816-123X
Zuyang YuanDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Asli YildirimDepartment of Microbiology, Immunology and Molecular Genetics, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Pin-Jung ChenDepartment of Surgery, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Paul WinogradDepartment of Surgery, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Benjamin TranDepartment of Surgery, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Yi-Te LeeDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0002-8177-0407
Paul Shize LiWestlake High School, 100N Lakeview Cyn Road, Westlake Village, CA, 91362, USA.
Zorawar NoorDepartment of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Megumi YokomizoDepartment of Radiological Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Preeti AhujaDepartment of Radiological Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Yazhen ZhuDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0002-2130-8085
Hsian-Rong TsengDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0003-0942-5905
James S TomlinsonDepartment of Surgery, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Edward GaronDepartment of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0001-7077-8801
Samuel FrenchDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0002-7611-881X
Clara E MagyarDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Sarah DryDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Clara LajonchereJonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Daniel GeschwindInstitute for Precision Health, University of California at Los Angeles, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0003-2896-3450
Gina ChoiDepartment of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Sammy SaabDepartment of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Frank AlberDepartment of Microbiology, Immunology and Molecular Genetics, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Wing Hung WongDepartment of Statistics, Stanford University, Stanford, CA, 94305, USA.ORCID http://orcid.org/0000-0001-7466-2339
Steven M DubinettDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Denise R AberleDepartment of Radiological Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Vatche AgopianDepartment of Surgery, University of California at Los Angeles, Los Angeles, CA, 90095, USA. vagopian@mednet.ucla.edu.ORCID http://orcid.org/0000-0003-0130-9838
Steven-Huy B HanDepartment of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA. steven.han@ucla.edu.ORCID http://orcid.org/0000-0003-1459-8763
Xiaohui NiEarlyDiagnostics, Inc., 570 Westwood Plaza, Los Angeles, CA, 90095, USA. xiaohui.ni@earlydx.com.ORCID http://orcid.org/0000-0002-3626-3588
Wenyuan LiDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA. wenyuanli@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-5029-8525
Xianghong Jasmine ZhouDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA. xjzhou@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-4522-7490

Funding

HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapyR01CA276917 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EDWARD B GARON · 2023 to 2026
$2.9M
NCI NIH HHS R01 CA276917
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38693151
PMCPMC11063198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.